EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cell Cycle Inhibitors In Cancer Therapy Cancer Drug Discovery And Development 1st Edition Antonio Giordano

SKU: BELL-2133620

$ 31.00 ~~$ 45.00~~ (-31%)

0 reviews

Cell Cycle Inhibitors In Cancer Therapy Cancer Drug Discovery And Development 1st Edition Antonio Giordano instant download after payment.

Publisher: Humana Press

File Extension: PDF

File size: 2.42 MB

Pages: 327

Author: Antonio Giordano, Kenneth J. Soprano

ISBN: 0896039307

Language: English

Year: 2002

Edition: 1

Product desciption

Cell Cycle Inhibitors In Cancer Therapy Cancer Drug Discovery And Development 1st Edition Antonio Giordano by Antonio Giordano, Kenneth J. Soprano 0896039307 instant download after payment.

Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. The book brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease.